• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕激素受体膜组份 1 及其同谋:肺癌治疗的新靶点。

Progesterone Receptor Membrane Component 1 and its Accomplice: Emerging Therapeutic Targets in Lung Cancer.

机构信息

Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur Campus, Tamil Nadu, Chennai 603203, India.

Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur Campus, Tamil Nadu, Chennai 603203, India.

出版信息

Endocr Metab Immune Disord Drug Targets. 2022;22(6):601-611. doi: 10.2174/1871530321666211130145542.

DOI:10.2174/1871530321666211130145542
PMID:34847852
Abstract

Progesterone receptor membrane component 1 (PGRMC1) is a trans-membrane evolutionarily conserved protein with a cytochrome b5 like heme/steroid binding domain. PGRMC1 clinical levels are strongly suggested to correlate with poor patient survival and lung cancer prognosis. PGRMC1 has been reported to possess pleiotropic functions, such as participating in cellular and membrane trafficking, steroid hormone signaling, cholesterol metabolism and steroidogenesis, glycolysis and mitochondrial energy metabolism, heme transport and homeostasis, neuronal movement and synaptic function, autophagy, anti-apoptosis, stem cell survival and the list is still expanding. PGRMC1 mediates its pleiotropic functions through its ability to interact with multiple binding partners, such as epidermal growth factor receptor (EGFR), sterol regulatory element binding protein cleavage activating protein (SCAP), insulin induced gene-1 protein (Insig-1), heme binding proteins (hepcidin, ferrochelatase and cyp450 members), plasminogen activator inhibitor 1 RNA binding protein (PAIR-BP1). In this review, we provide a comprehensive overview of PGRMC1 and its associated pleiotropic functions that are indispensable for lung cancer promotion and progression, suggesting it as a prospective therapeutic target for intervention. Notably, we have compiled and reported various preclinical studies wherein prospective agonists and antagonists had been tested against PGRMC1 expressing cancer cell lines, suggesting it as a prospective therapeutic target for cancer intervention.

摘要

孕激素受体膜成分 1(PGRMC1)是一种跨膜进化上保守的蛋白,具有细胞色素 b5 样血红素/甾体结合域。PGRMC1 的临床水平强烈提示与患者生存不良和肺癌预后相关。据报道,PGRMC1 具有多种功能,如参与细胞和膜运输、甾体激素信号转导、胆固醇代谢和甾体生成、糖酵解和线粒体能量代谢、血红素转运和动态平衡、神经元运动和突触功能、自噬、抗细胞凋亡、干细胞存活等,而且这个列表还在不断扩大。PGRMC1 通过与多种结合伴侣相互作用来介导其多种功能,如表皮生长因子受体(EGFR)、固醇调节元件结合蛋白裂解激活蛋白(SCAP)、胰岛素诱导基因-1 蛋白(Insig-1)、血红素结合蛋白(hepcidin、亚铁螯合酶和 CYP450 成员)、纤维蛋白溶酶原激活物抑制剂 1 RNA 结合蛋白(PAIR-BP1)。在这篇综述中,我们全面概述了 PGRMC1 及其相关的多效性功能,这些功能对于肺癌的促进和进展是不可或缺的,表明它是一种有前途的治疗干预靶点。值得注意的是,我们已经编译并报告了各种临床前研究,其中已经针对表达 PGRMC1 的癌细胞系测试了潜在的激动剂和拮抗剂,表明它是癌症干预的一个有前途的治疗靶点。

相似文献

1
Progesterone Receptor Membrane Component 1 and its Accomplice: Emerging Therapeutic Targets in Lung Cancer.孕激素受体膜组份 1 及其同谋:肺癌治疗的新靶点。
Endocr Metab Immune Disord Drug Targets. 2022;22(6):601-611. doi: 10.2174/1871530321666211130145542.
2
Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule.孕激素受体膜组份 1(Pgrmc1):一种血红素-1 结构域蛋白,可促进肿瘤发生,并被小分子抑制。
J Pharmacol Exp Ther. 2010 May;333(2):564-73. doi: 10.1124/jpet.109.164210. Epub 2010 Feb 17.
3
PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.孕激素受体膜组分1(PGRMC1):一种在类固醇信号传导、细胞色素P450激活和药物结合中具有多种功能的可靶向蛋白。
Pharmacol Ther. 2009 Jan;121(1):14-9. doi: 10.1016/j.pharmthera.2008.09.006. Epub 2008 Nov 1.
4
Thoughts on interactions between PGRMC1 and diverse attested and potential hydrophobic ligands.关于PGRMC1与多种已证实及潜在疏水配体之间相互作用的思考。
J Steroid Biochem Mol Biol. 2017 Jul;171:11-33. doi: 10.1016/j.jsbmb.2016.12.020. Epub 2017 Jan 16.
5
Functions of MAPR (membrane-associated progesterone receptor) family members as heme/steroid-binding proteins.MAPR(膜相关孕激素受体)家族成员作为血红素/甾体结合蛋白的功能。
Curr Protein Pept Sci. 2012 Nov;13(7):687-96. doi: 10.2174/138920312804142110.
6
Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression.孕激素受体膜成分 1 调节脂质稳态并驱动致癌信号转导,导致乳腺癌进展。
Breast Cancer Res. 2020 Jul 13;22(1):75. doi: 10.1186/s13058-020-01312-8.
7
S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling.S2R(Pgrmc1):与细胞色素相关的 sigma-2 受体,调节脂质和药物代谢以及激素信号转导。
Expert Opin Drug Metab Toxicol. 2012 Mar;8(3):361-70. doi: 10.1517/17425255.2012.658367. Epub 2012 Feb 1.
8
The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology.孕激素受体膜成分1(PGRMC1)在癌症生物学中的新作用。
Biochim Biophys Acta. 2016 Dec;1866(2):339-349. doi: 10.1016/j.bbcan.2016.07.004. Epub 2016 Jul 22.
9
Progesterone receptor membrane component 1 (PGRMC1) binds and stabilizes cytochromes P450 through a heme-independent mechanism.孕激素受体膜成分 1(PGRMC1)通过一种非血红素依赖的机制结合并稳定细胞色素 P450。
J Biol Chem. 2021 Nov;297(5):101316. doi: 10.1016/j.jbc.2021.101316. Epub 2021 Oct 20.
10
Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1.孕激素诱导的 HEK293 细胞瓦博格效应与孕激素受体膜成分 1 的翻译后修饰和蛋白酶体降解有关。
J Steroid Biochem Mol Biol. 2019 Jul;191:105376. doi: 10.1016/j.jsbmb.2019.105376. Epub 2019 May 5.

引用本文的文献

1
Pleiotropy of Progesterone Receptor Membrane Component 1 in Modulation of Cytochrome P450 Activity.孕激素受体膜组分1在调节细胞色素P450活性中的多效性
J Xenobiot. 2024 May 1;14(2):575-603. doi: 10.3390/jox14020034.
2
Targeting human progesterone receptor (PR), through pharmacophore-based screening and molecular simulation revealed potent inhibitors against breast cancer.通过基于药效团的筛选和分子模拟靶向人孕激素受体(PR),发现了针对乳腺癌的有效抑制剂。
Sci Rep. 2024 Mar 21;14(1):6768. doi: 10.1038/s41598-024-55321-0.
3
Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer.
针对非小细胞肺癌的 Akt-1 变构抑制剂的计算药物再利用。
Sci Rep. 2023 May 16;13(1):7947. doi: 10.1038/s41598-023-35122-7.
4
Pleiotropic Actions of PGRMC Proteins in Cancer.PGRMC 蛋白在癌症中的多效性作用。
Endocrinology. 2022 Jul 1;163(7). doi: 10.1210/endocr/bqac078.